Supernus Pharmaceuticals, Inc. (SUPN) Earnings
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$26.43
+1.03%
Mkt Cap $2.11B
EPS — Estimate vs Actual
Mkt Cap
$2.11B
P/E
—
Fwd P/E
25.99
P/S
2.72
Rev TTM
—
EPS TTM
-$0.51
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$26.43
+1.03%
Mkt Cap $2.11B
Mkt Cap
$2.11B
P/E
—
Fwd P/E
25.99
P/S
2.72
Rev TTM
—
EPS TTM
-$0.51